Co-Founder/Chief Executive Officer
Mr. Haig has a proven track record with more than 25 years of experience in the field of medical technology, primarily in the domain of cardiovascular devices, at large, multi-national corporations as well as growth-phase companies with novel technologies. At Guidant Corporation and Abbott Vascular, he held numerous positions of increasing responsibility in marketing, sales and business development functions. Mr. Haig also has extensive start-up experience in senior management positions at Calypso Medical (acquired by Varian Medical Systems) and QT Vascular (S$55 million IPO in 2014), where he built the company’s commercial infrastructure and successfully launched several innovative devices. He holds a B.A. degree from UC Berkeley and an M.B.A. degree from the Kenan Flagler School of Management at the University of North Carolina, Chapel Hill.
Co-Founder/Chief Medical Officer
Dr. Schwartz is a vascular surgeon at Lutheran General Hospital in Niles, IL, and Professor of Vascular Surgery at The University of Illinois Medical Center in Chicago, IL. In 2003, Dr. Schwartz joined Abbott Laboratories as Global Medical Director for Thrombolysis, and was subsequently named Divisional Vice President of the Abbott Vascular division. In that position, he directed several programs involving novel drug-device combinations for coronary and peripheral vascular disease, including initiation of the first clinical trials of drug-eluting, bioresorbable stents for the treatment of peripheral artery disease (PAD). Dr. Schwartz and his team successfully secured the first indication for a peripheral drug-eluting stent in Abbott’s history. In 2013, Dr. Schwartz was named Vice President, Global Device Development, for Hospira, Inc., the world’s leading manufacturer of generic injectable pharmaceuticals and infusion pumps. During his tenure at Hospira, he participated in restoring safety and regulatory compliance and reinvigorated the company’s medical device pipeline. He completed medical school at The University of Chicago, general surgical residency at Duke University, and vascular surgical fellowship at Brigham and Women’s Hospital (Harvard).